EUVIMEDEUVIMED entdecken
Open Access

Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity

Henrique B Abdalla iD, Carla Alvarez, Yu-Chiao Wu, Paola Rojas, Bruce D Hammock iD, Krishna R Maddipati, Carlos Antonio Trindade-da-Silva, Mariana Q S Soares, Juliana T Clemente-Napimoga, Alpdogan Kantarci, Marcelo H Napimoga, Thomas E Van Dyke

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2023. Verfasst von Henrique B Abdalla und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Oral Sciences, The Forsyth Institute, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Epoxide Hydrolases, Periodontitis. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NIEHS NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Epoxyeicosatrienoic acids (EETs) and other epoxy fatty acids (EpFA) are lipid mediators that are rapidly inactivated by soluble epoxide hydrolase (sEH). Uncontrolled and chronic inflammatory disorders fail to sufficiently activate endogenous regulatory pathways, including the production of specialized pro‐resolving mediators (SPMs). Here, we addressed the relationship between SPMs and the EET/sEH axis and explored the effects of sEH inhibition on resolving macrophage phenotype. Experimental Approach Mice were treated with a sEH inhibitor, EETs, or sEH inhibitor + EETs (combination) before ligature placement to induce experimental periodontitis. Using RT‐qPCR, gingival samples were used to examine SPM receptors and osteolytic and inflammatory biomarkers. Maxillary alveolar bone loss was quantified by micro‐CT and methylene blue staining. SPM levels were analysed by salivary metabolo‐lipidomics. Gingival macrophage phenotype plasticity was determined by RT‐qPCR and flow cytometry. Effects of sEH inhibition on macrophage polarization and SPM production were assessed with bone marrow‐derived macrophages (BMDMs). Key Results Pharmacological inhibition of sEH suppressed bone resorption and the inflammatory cytokine storm in experimental periodontitis. Lipidomic analysis revealed that sEH inhibition augmented levels of LXA4, RvE1, RvE2, and 4‐HDoHE, concomitant with up‐regulation of LTB4R1, CMKLR1/ChemR23, and ALX/FPR2 SPM receptors. Notably, there is an impact on gingival macrophage plasticity was affected suggesting an inflammation resolving phenotype with sEH inhibition. In BMDMs, sEH inhibition reduced inflammatory macrophage activation, and resolving macrophages were triggered to produce SPMs. Conclusion and Implications Pharmacological sEH inhibition increased SPM synthesis associated with resolving macrophages, suggesting a potential target to control osteolytic inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epoxide HydrolasesPeriodontitisAnimalsMiceMacrophagesInflammationEicosanoidsReceptors, Leukotriene B4

Stichwörter der Autor:innen

inflammationmacrophageperiodontal diseasesoluble epoxide hydrolase inhibitionspecialized pro-resolving mediators (SPMs)

Substanzen

Epoxide HydrolasesEicosanoidsLtb4r1 protein, mouseReceptors, Leukotriene B4

Autor:innen und Institutionen

  • Department of Applied Oral Sciences, The Forsyth Institute, Cambridge, Massachusetts, USA.
  • Laboratory of Neuroimmune Interface of Pain Research, Faculdade São Leopoldo Mandic, Instituto de Pesquisa São Leopoldo Mandic, Campinas, Brazil.
  • Harvard School of Dental Medicine, Boston, Massachusetts, USA.
  • Department of Entomology and UCD Comprehensive Cancer Center, University of California, Davis, California, USA.
  • Department of Pathology, Wayne State University, Detroit, Michigan, USA.
  • Department of Oral Medicine, Infection, and Immunity, Faculty of Medicine, Harvard University, Boston, Massachusetts, USA.

ORCID-Profile: Henrique B Abdalla, Bruce D Hammock

Förderung

  • NIDCR NIH HHS
  • NIEHS NIH HHS
  • NCRR NIH HHS
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • National Institute of Environmental Health Sciences
  • U.S. Public Health Service

Zitieren

APA

Abdalla, H. B., Alvarez, C., Wu, Y. C., Rojas, P., Hammock, B. D., Maddipati, K. R., Trindade-da-Silva, C. A., Soares, M. Q. S., Clemente-Napimoga, J. T., Kantarci, A., Napimoga, M. H., & Van Dyke, T. E. (2023). Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity. British Journal of Pharmacology. https://doi.org/10.1111/bph.16009

Vancouver

Abdalla HB, Alvarez C, Wu YC, Rojas P, Hammock BD, Maddipati KR, et al. Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity. British Journal of Pharmacology. 2023. doi:10.1111/bph.16009

BibTeX
@article{Abdalla2023,
  author = {Abdalla, Henrique B and Alvarez, Carla and Wu, Yu-Chiao and Rojas, Paola and Hammock, Bruce D and Maddipati, Krishna R and Trindade-da-Silva, Carlos Antonio and Soares, Mariana Q S and Clemente-Napimoga, Juliana T and Kantarci, Alpdogan and Napimoga, Marcelo H and Van Dyke, Thomas E},
  title = {Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16009}
}
Kostenlos starten →